Consultorios Medicos Dr. Doreski - Fundacion Respirar

Buenos Aires 1426

1 studies enrolling now · 2 studies all time

What they study most

Indolent Systemic Mastocytosis, Non-small Cell Lung Cancer, Smoldering Systemic Mastocytosis

Studies at this site

• (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis — Recruiting now
• A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) — Running, not enrolling